Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular...
Carisma Therapeutics to Participate in the Stifel 2024 Cell Therapy Forum PR Newswire PHILADELPHIA, June 25...
Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders PR Newswire PHILADELPHIA, June...
provided pursuant to article L.233-8 II of the Code de commerce (French Commercial Code) and article 223-16 of the Règlement général de...
Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference PR Newswire PHILADELPHIA...
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel...
Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights PR...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.